This trial tests whether adding a cartilage matrix product to microfracture treatment of ankle cartilage defects improves healing and pain/function.
- Osteochondral Defect
1 Primary · 6 Secondary · Reporting Duration: There are 6 assessment time points: within 21 days of surgery, 6 weeks post-op, 12 weeks post-op, 6 months post-op, 1 year post-op and 2 years post-op.
Awards & Highlights
2 Treatment Groups
1 of 2
1 of 2
15 Total Participants · 2 Treatment Groups
Primary Treatment: Group II · No Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · All Participants · 5 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Is enrollment for this study still available to participants?
"Affirmative. The information posted on clinicaltrials.gov verifies that this research is actively seeking participants, with the first posting having been made on January 29th 2019 and most recently updated April 2nd of last year. This study requires 15 individuals to be recruited from 1 medical centre." - Anonymous Online Contributor
How many participants are included in the clinical trial?
"Affirmative. According to information located on clinicaltrials.gov, this medical experiment is still searching for participants since its initial posting on January 29th 2019 and the latest update being April 2nd 2019. The study requires 15 patients from a single location." - Anonymous Online Contributor